
News from Stockhead
We’ve assigned a rating of Unknown factuality to Stockhead. You can read more about how we’ve determined Stockhead’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Stockhead News

IPO · United States(MedPage Today) -- Anti-factor XIIa biologic garadacimab (Andembry) got the FDA greenlight for use in preventing hereditary angioedema (HAE) attacks in adult and pediatric patients ages 12 years and older, CSL announced.
Garadacimab is the only...See the Story
FDA Approves Once-Monthly Hereditary Angioedema Drug
62% Center coverage: 32 sources

US Politics · United StatesCritical Metals Corp has received a letter of interest from the U.S. Export-Import Bank (EXIM) for a loan worth up to $120 million to fund the company’s Tanbreez rare earths mine in Greenland, in what would be the Trump administration’s first overseas investment in a mining project.See the Story
US Ex-Im Bank May Fund Greenland Rare Earths Mine, Reuters Says
39% Left coverage: 23 sources